INTS vs KLAC
Intensity Therapeutics, Inc. Common stock (INTS) versus KLA Corporation (KLAC) — a side-by-side from cached financials, not a winner call.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
KLA Corporation (KLAC) is a semiconductor equipment & materials company listed on US.
INTS does not have a complete income-statement cache yet.
Latest reported KLAC revenue for 2025-06-30 was $12.16B. Net income was $4.06B. KLAC currently screens at market cap $252.01B and trailing P/E 54.7.
INTS currently screens at market cap $7.7M. KLAC currently screens at market cap $252.01B and trailing P/E 54.7.
Not investment advice. Open the INTS and KLAC stock pages for the full models.
Not investment advice.